Volpe and Koenig announced that Robert S. Silver has recently joined the firm’s Philadelphia office as a shareholder.

As an active intellectual property litigator, Silver has developed a global practice representing generic pharmaceutical companies particularly in complex suits involving paragraph IV challenges under the Hatch-Waxman Act regarding Abbreviated New Drug Applications (ANDA).